Q3 2026 Earnings

EX-99.1 2 slp-2026531xexx991x263.htm EX-99.1 Document Exhibit 99.1 Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results RESEARCH TRIANGLE PARK, NC, July 9, 2026 – Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its third quarter fiscal 2026, ended May 31, 2026. Third Quarter 2026 Financial Highlights (as compared to third quarter 2025) • Total revenue increased 7% to $21.9 million • Software revenue was flat at $12.6 million, representing 58% of total revenue • Services revenue increased 20% to $9.3 million, representing 42% of total revenue • Gross profit was $15.1 million and gross margin was 69%, compared to $13.0 million and 64% • Net income of $3.6 million and diluted earnings per share of $0.18, co...